Search

everythinglearnresearchcommunity

for

Search:↓

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

A new gel containing minoxidil can treat hair loss effectively, potentially reducing side effects and improving treatment.

Personalized, minimally invasive treatments improve urology outcomes.

Using mirabegron and solifenacin together is safe and more effective for treating overactive bladder than using either drug alone.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Researchers developed a mouse model that successfully mimics the bladder damage seen in humans after radiation therapy.

Some plants with flavonoids may help treat hair loss and promote hair growth.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

PRP shows promise in treating urological diseases but needs more research.

Phage therapy could be a safe and effective new treatment for acne.

5α-reductase inhibitors may lower the risk of death from bladder cancer.

The book concludes that despite progress, cancer drug treatments have not met the expectations set in the 1960s and 1970s.

The review suggests new ways to classify ejaculation problems and recommends different treatments based on the type of issue.

Mesenchymal stem cells could help treat radiation-induced bladder damage but more research is needed to overcome current limitations.

Extracellular vesicles show promise for medical use but face challenges in standardization and safety.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

Underactive bladder is hard to diagnose and treat, needing more research.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

Capsaicin offers health benefits and flavor but faces challenges in food use.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

Combining hyperthermia with natural compounds and conventional treatments improves cancer therapy effectiveness and reduces side effects.

Biodegradable polymers can improve cannabinoid delivery but need more clinical trials.

Peptide-based PROTACs show promise in targeting hard-to-treat proteins, especially for cancer therapy.

Platelet-rich plasma shows promise in reducing pain for bladder pain syndrome.

A new score can help predict which patients might have trouble urinating after prostate surgery.

Intraprostatic injection and high-frequency thermotherapy are more effective for treating prostatitis after TURP than antibiotics, tamsulosin, and finasteride.